| scholarly article | Q13442814 |
| P50 | author | Klaus H Metzeler | Q40607412 |
| Stefan Bohlander | Q41129702 | ||
| P2093 | author name string | Ulrich Mansmann | |
| Wolfgang E Berdel | |||
| Achim Heinecke | |||
| Wolfgang Hiddemann | |||
| Christian Buske | |||
| Thomas Büchner | |||
| Manuela Hummel | |||
| Bernhard Wörmann | |||
| Karsten Spiekermann | |||
| Annika Dufour | |||
| Jan Braess | |||
| Tobias Benthaus | |||
| Maria-Cristina Sauerland | |||
| P433 | issue | 30 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| acute myeloid leukemia | Q264118 | ||
| P304 | page(s) | 5031-5038 | |
| P577 | publication date | 2009-09-14 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays | |
| P478 | volume | 27 |
| Q98771303 | A Novel Immune-Related Competing Endogenous RNA Network Predicts Prognosis of Acute Myeloid Leukemia |
| Q89341420 | A novel scoring system for acute myeloid leukemia risk assessment based on the expression levels of six genes |
| Q37507603 | A quantitative proteomics approach identifies ETV6 and IKZF1 as new regulators of an ERG-driven transcriptional network. |
| Q42267678 | A standardized microarray assay for the independent gene expression markers in AML: EVI1 and BAALC. |
| Q38027047 | Acute myeloid leukemia with normal cytogenetics |
| Q41838202 | BAALC and ERG Expression in Egyptian Patients with Acute Myeloid Leukemia, Relation to Survival and Response to Treatment |
| Q34541748 | BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study |
| Q41885481 | BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia |
| Q50913559 | BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients. |
| Q37575953 | Comprehensive study on ERG gene expression in normal karyotype acute myeloid leukemia: ERG expression is of limited prognostic value, whereas the accumulation of adverse prognostic markers stepwise worsens the prognosis |
| Q39337506 | Copy-number analysis identified new prognostic marker in acute myeloid leukemia |
| Q33776896 | E-26 Transformation-specific Related Gene Expression and Outcomes in Cytogenetically Normal Acute Myeloid Leukemia: A Meta-analysis |
| Q41109922 | ERG Is a Useful Immunohistochemical Marker to Distinguish Leukemia Cutis From Nonneoplastic Leukocytic Infiltrates in the Skin |
| Q36395611 | ERG and FLI1 binding sites demarcate targets for aberrant epigenetic regulation by AML1-ETO in acute myeloid leukemia |
| Q28484833 | ERG transcriptional networks in primary acute leukemia cells implicate a role for ERG in deregulated kinase signaling |
| Q37594153 | ETS-related gene is a novel prognostic factor in childhood acute lymphoblastic leukemia |
| Q96640393 | Effective drug treatment identified by in vivo screening in a transplantable patient-derived xenograft model of chronic myelomonocytic leukemia |
| Q34542996 | Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia |
| Q53109363 | Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach. |
| Q53409067 | Functional role of BAALC in leukemogenesis. |
| Q86636781 | Gain of chromosome 21 or amplification of chromosome arm 21q is one mechanism for increased ERG expression in acute myeloid leukemia |
| Q54550981 | Gene expression of BAALC, CDKN1B, ERG, and MN1 adds independent prognostic information to cytogenetics and molecular mutations in adult acute myeloid leukemia. |
| Q37226744 | Genome-scale expression and transcription factor binding profiles reveal therapeutic targets in transgenic ERG myeloid leukemia |
| Q42748236 | Giant seminoma in an undescended testicle metastasizing to the neck and liver |
| Q35922032 | Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia |
| Q47156797 | High BAALC copy numbers in peripheral blood prior to allogeneic transplantation predict early relapse in acute myeloid leukemia patients |
| Q41670609 | High IDH1 expression is associated with a poor prognosis in cytogenetically normal acute myeloid leukemia |
| Q92567745 | High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia |
| Q38301831 | High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. |
| Q35741669 | High expression of inositol 1,4,5-trisphosphate receptor, type 2 (ITPR2) as a novel biomarker for worse prognosis in cytogenetically normal acute myeloid leukemia |
| Q37351908 | Human BDH2, an anti-apoptosis factor, is a novel poor prognostic factor for de novo cytogenetically normal acute myeloid leukemia |
| Q33897586 | IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study |
| Q42724137 | Impact of molecular prognostic factors in cytogenetically normal acute myeloid leukemia at diagnosis and relapse |
| Q43938731 | Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal acute myeloid leukemia |
| Q45847205 | LMO2 (LIM domain only 2) is expressed in a subset of acute myeloid leukaemia and correlates with normal karyotype |
| Q35794120 | Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemia |
| Q30277014 | MAPK/ERK2 phosphorylates ERG at serine 283 in leukemic cells and promotes stem cell signatures and cell proliferation. |
| Q36737896 | MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia |
| Q47117304 | Meis2 as a critical player in MN1-induced leukemia. |
| Q52655669 | MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia. |
| Q26998811 | Molecular prognostic factors in cytogenetically normal acute myeloid leukemia |
| Q41891342 | New strategies in acute myeloid leukemia: redefining prognostic markers to guide therapy |
| Q37552027 | Normal karyotype is a poor prognostic factor in myeloid leukemia of Down syndrome: a retrospective, international study. |
| Q92996721 | Not Only Mutations Matter: Molecular Picture of Acute Myeloid Leukemia Emerging from Transcriptome Studies |
| Q37810969 | Older patients with acute myeloid leukemia |
| Q99205342 | Over-expression of BAALC and ERG is associated with poor outcome in acute myeloid leukemia |
| Q48446071 | Overexpression of BAALC: clinical significance in Chinese de novo acute myeloid leukemia |
| Q42183867 | Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias |
| Q47863498 | Pediatric Acute Megakaryoblastic Leukemia: Multitasking Fusion Proteins and Oncogenic Cooperations. |
| Q37954583 | Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics |
| Q45168760 | Prognostic significance of combined MN1, ERG, BAALC, and EVI1 (MEBE) expression in patients with myelodysplastic syndromes |
| Q35690315 | Prognostic significance of the BAALC gene expression in adult patients with acute myeloid leukemia: A meta-analysis |
| Q40531872 | RNA and protein expression of herpesvirus entry mediator (HVEM) is associated with molecular markers, immunity-related pathways and relapse-free survival of patients with AML. |
| Q38823486 | Reduced Erg Dosage Impairs Survival of Hematopoietic Stem and Progenitor Cells |
| Q28771722 | Targeting the DNA-binding activity of the human ERG transcription factor using new heterocyclic dithiophene diamidines |
| Q34766817 | The Prognostic Relevance of BAALC and ERG Expression Levels in Cytogenetically Normal Pediatric Acute Myeloid Leukemia. |
| Q43631164 | The clinical relevance of BAALC and ERG expression levels in pediatric AML. |
| Q57286200 | The modular network structure of the mutational landscape of Acute Myeloid Leukemia |
| Q37738548 | The role of molecular tests in acute myelogenous leukemia treatment decisions |
| Q38733887 | The unusual monomer recognition of guanine-containing mixed sequence DNA by a dithiophene heterocyclic diamidine |
| Q84782684 | Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases |
| Q38235586 | Translational implications of somatic genomics in acute myeloid leukaemia. |
Search more.